Aignostics Raises €14m Series A to Advance AI-powered Pathology

Oversubscribed financing round with top-tier life science investors, led by Wellington Partners Spin-off from Charité – Universitätsmedizin Berlin developing

Related Keywords

Germany ,Boston ,Massachusetts ,United States ,Wellington ,New Zealand General ,New Zealand ,Munich ,Bayern ,Berlin ,German ,Maximilian Alber ,Rainer Strohmenger ,Johannes Fischer ,Alexander Ehlgen ,Frederick Klauschen ,Oxford Immunotec ,Viktor Matyas ,Roche Ventana ,European Regional Development Fund ,Digital Health Accelerator ,Berlin Institute Of Health ,Boston Scientific ,Boehringer Ingelheim Venture Fund ,Perkinelmer ,Fund Investors ,Ministry For Economic Affairs ,Boehringer Ingelheim Venture Fund Gmb ,Good Clinical Practice ,Companion Diagnostic ,Managing Partner ,Wellington Partners ,Berlin Institute ,Boehringer Ingelheim Venture Fund Gmbh ,Investitionsbank Berlin ,Federal Ministry ,Economic Affairs ,Climate Action ,Kfw Capital ,Life Science ,First Closing ,Aignostics ,Raises ,24m ,Series ,A ,To ,Advance ,Ai Powered ,Pathology ,